Literature DB >> 19571133

Neurobehavioral performance in feline immunodeficiency virus infection: integrated analysis of viral burden, neuroinflammation, and neuronal injury in cortex.

Ferdinand Maingat1, Pornpun Vivithanaporn, Yu Zhu, Andrew Taylor, Glen Baker, Keir Pearson, Christopher Power.   

Abstract

Human immunodeficiency virus (HIV) infection causes motor and neurocognitive abnormalities affecting >50% of children and 20% of adults with HIV/AIDS (acquired immunodeficiency syndrome). The closely related lentivirus, feline immunodeficiency virus (FIV), also causes neurobehavioral deficits. Herein, we investigated the extent to which FIV infection affected specific motor and cognitive tasks in conjunction with viral burden and immune responses within the brain. Neonatal animals were infected with a neurovirulent FIV strain (FIV-Ch) and assessed in terms of systemic immune parameters, viral burden, neurobehavioral performance, and neuropathological features. FIV-infected animals displayed less weight gain and lower blood CD4(+) T-cell levels than mock-infected animals (p < 0.05). Gait analyses disclosed greater gait width with increased variation in FIV-infected animals (p < 0.05). Maze performance showed that FIV-infected animals were slower and made more navigational errors than mock-infected animals (p < 0.05). In the object memory test, the FIV-infected group exhibited fewer successful steps with more trajectory errors compared with the mock-infected group (p < 0.05). Performance on the gait, maze, and object memory tests was inversely correlated with F4/80 and CD3 epsilon expression (p < 0.05) and with viral burden in parietal cortex (p < 0.05). Amino acid analysis in cortex showed that D-serine levels were reduced in FIV-infected animals, which was accompanied by diminished kainate and AMPA receptor subunit expression (p < 0.05). The neurobehavioral findings in FIV-infected animals were associated with increased gliosis and reduced cortical neuronal counts (p < 0.05). The present studies indicated that specific motor and neurocognitive abilities were impaired in FIV infection and that these effects were closely coupled with viral burden, neuroinflammation, and neuronal loss.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19571133      PMCID: PMC6665675          DOI: 10.1523/JNEUROSCI.5818-08.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  13 in total

Review 1.  Editorial neuroAIDS review.

Authors:  Paul Shapshak; Pandjassarame Kangueane; Robert K Fujimura; Deborah Commins; Francesco Chiappelli; Elyse Singer; Andrew J Levine; Alireza Minagar; Francis J Novembre; Charurut Somboonwit; Avindra Nath; John T Sinnott
Journal:  AIDS       Date:  2011-01-14       Impact factor: 4.177

Review 2.  Neuropathogenesis of HIV-1-associated neurocognitive disorders: a possible involvement of D-serine.

Authors:  Jianxun Xia; Huangui Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-09-10

3.  Proteinase-activated receptor-1 mediates dorsal root ganglion neuronal degeneration in HIV/AIDS.

Authors:  Shaona Acharjee; Yu Zhu; Ferdinand Maingat; Carlos Pardo; Klaus Ballanyi; Morley D Hollenberg; Christopher Power
Journal:  Brain       Date:  2011-10-21       Impact factor: 13.501

4.  The use of a T-maze to measure cognitive-motor function in cats (Felis catus).

Authors:  Barbara L Sherman; Margaret E Gruen; Rick B Meeker; Bill Milgram; Christina DiRivera; Andrea Thomson; Gillian Clary; Lola Hudson
Journal:  J Vet Behav       Date:  2013-01       Impact factor: 1.975

Review 5.  Single-Cell RNA-Sequencing: Astrocyte and Microglial Heterogeneity in Health and Disease.

Authors:  Michael S Spurgat; Shao-Jun Tang
Journal:  Cells       Date:  2022-06-24       Impact factor: 7.666

6.  Differential type 1 interferon-regulated gene expression in the brain during AIDS: interactions with viral diversity and neurovirulence.

Authors:  Maria J Polyak; Pornpun Vivithanaporn; Ferdinand G Maingat; John G Walsh; William Branton; Eric A Cohen; Rick Meeker; Christopher Power
Journal:  FASEB J       Date:  2013-04-22       Impact factor: 5.191

Review 7.  Neurologic disease in feline immunodeficiency virus infection: disease mechanisms and therapeutic interventions for NeuroAIDS.

Authors:  Christopher Power
Journal:  J Neurovirol       Date:  2017-12-15       Impact factor: 2.643

8.  Rapid inflammasome activation in microglia contributes to brain disease in HIV/AIDS.

Authors:  John G Walsh; Stacey N Reinke; Manmeet K Mamik; Brienne A McKenzie; Ferdinand Maingat; William G Branton; David I Broadhurst; Christopher Power
Journal:  Retrovirology       Date:  2014-05-13       Impact factor: 4.602

9.  Improved neurocognitive performance in FIV infected cats following treatment with the p75 neurotrophin receptor ligand LM11A-31.

Authors:  Jonathan E Fogle; Lola Hudson; Andrea Thomson; Barbara Sherman; Margaret Gruen; B Duncan Lacelles; Brenda M Colby; Gillian Clary; Frank Longo; Rick B Meeker
Journal:  J Neurovirol       Date:  2021-03-04       Impact factor: 3.739

10.  Brain microbial populations in HIV/AIDS: α-proteobacteria predominate independent of host immune status.

Authors:  William G Branton; Kristofor K Ellestad; Ferdinand Maingat; B Matt Wheatley; Erling Rud; René L Warren; Robert A Holt; Michael G Surette; Christopher Power
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.